antitubercular, antidiabetic and antimalarial activities (4) . Benzimidazoles are heterocyclic compounds having various biological activities (5) , among which albendazole, mebendazole and thiabendazole are widely used anthelmintic drugs. Furthermore, benzimidazole compounds are also reported to possess biological activities such as inhibition of the angiopoietin receptor TIE-2 and tyrosine kinase receptor VEGFR-2 (vascular endothelial growth factor receptor-2), antitumor activity, thrombopoietin receptor agonistic activity, gamma-aminobutyric acid (GABA) agonistic activity, antimicrobial activity, topoisomerase inhibition, neuropeptide Y1 receptor antagonistic activity and inhibition of angiotensin II. Tetrazoles can act as pharmacophores for the carboxylate group and increase its utility (6, 7) . Angiotensin II blockers often contain tetrazoles such as losartan and candesartan. A well-known tetrazole is dimethyl thiazolyl diphenyl tetrazolium salt (MTT), which is used in the MTT assay to quantify the respiratory activity of live cells in cell cultures, although it kills the cells in the process. Recent observations suggest that substituted benzoxazoles and related heterocycles possess potential activity with lower toxicity in the chemotherapeutic approach in man (8) . Careful literature survey revealed that targets containing benzoxazole moiety, either isolated from plants or accessed by total synthesis, have remarkable biological activities, such as antimicrobial, antihistaminic, antiparasitic, herbicidal, antiallergic and antihelmintic activities. They were screened for cytotoxic activity by the MTT assay.
EXPERIMENTAL
Melting points were determined with a digital melting point apparatus (LAB India MR-VIS, India) and are uncorrected. Elemental analyses were performed on a Perkin--Elmer 2400 analyzer (Perkin-Elmer, USA) and were found within ± 0.4 % of the theoretical values. FTIR spectra were recorded on a Shimadzu FT-IR model spectrophotometer (Japan). 1 H NMR spectra were recorded in DMSO on a Bruker AV III 500 MHz (USA) using TMS as internal standard. Mass spectra were recorded on a JEOL GCmate instrument (Japan). The purity of the compounds was checked by TLC on pre-coated silica gel G (HF 254 ) aluminium plates (Merck, USA) using chloroform/methanol (4:1) and visualized in a UV chamber.
Compounds 3-(4-(2-methyl-4-oxoquinazolin-3(4H)-yl)phenylamino)propanenitrile (1), 3,3'-(4,4'-sulfonylbis(4,1-phenylene)bis(azanediyl))dipropanenitrile (6), 3,3'-(6-phenyl--1,3,5-triazine-2,4-diyl)bis(azanediyl)dipropanenitrile (12) and 3,3,3',1,3,5-triazine-2,4,6--triyl)tris(azanediyl)tripropanenitrile (18) were prepared from primary amine by treatment with acrylonitrile and Triton B following reported literature (9) .
Syntheses of benzoxazoles, imidazoles and benzimidazoles. 
Syntheses of tetrazole (4,4'-sulfonylbis(N-(2-(1H-tetrazole-5-yl)ethyl)aniline) (10), N-bis-(2-1H-tetrazol-5-yl)ethyl)-6-phenyl-1,3,5-triazine-2,4-diamine (16) and N-tris(2-(1H-tetrazol--5-yl)ethyl)-1,3,5-triazine-2,4,6-triamine (22).
To a mixture of compound (3-(4-(2-methyl-4-oxoquinazolin-3(4H)-yl)phenylamino)propanenitrile (1) (0.01 mol, 2.13 g), 3,3'-(4,4'-sulfonylbis(4,1-phenylene)bis(azanediyl))dipropanenitrile (6) (0.01 mol, 3.54 g), 3,3'-(6-phenyl-1,3,5-triazine-2,4-diyl)bis(azanediyl)dipropanenitrile (12) (0.01 mol, 2.93 g) or 3,3,3',1,3,5-triazine-2,4,6-triyl)tris(azanediyl)tripropanenitrile (18) (0.01 mol, 2.85 g), sodium azide (0.01 mol, 0.65 g), dimethylformamide (10 mL) and NH 4 Cl (0.1 mol, 5.3 g) was placed in a 100-mL round-bottomed flask. The content was heated in oil bath for seven hours at 125°C. The solvent was removed at reduced pressure. The reaction mixture was dissolved in 100 mL distilled water and carefully acidified with dil. HCl (1:1) (2 mL) to make solution of pH 2. The solution was cooled to 5 o C in an ice bath. The product was isolated by filtration, washed with several portions of water and dried. The crude product was recrystallized from DMF.
Physicochemical and spectral data for the synthesized compounds are given in Tables I and II. Synthetic routes are presented in Schemes 1-4. 
MTT assay
The tumor cell growth inhibition activities of the newly synthesized compounds were assessed in vitro on the human cancer cell line MCF-7 (breast cancer) and HT-29 (colon cancer) obtained from the National Centre for Cell Sciences (NCCS), Pune, India. 5-Fluorouracil (Merck, Germany) was used as a standard.
Cultured cells were trypsinized and resuspended in growth medium. The cells were seeded at 1´10 5 cells per well in a 96-well plate and incubated for 24 h in a CO 2 incubator. The cells were treated with different concentrations (1, 5, 10, 12.5, 25, 50, 75, 100, 125 and 250 µg mL -1 ) of test compounds and then incubated for 24 h in the CO 2 incubator. To each well, 10 µL of MTT reagent was added and they were again incubated for 4 h at 37°C. Each experiment was done in triplicate. The content of each well was transferred to a different Eppendorf tube and centrifuged at 2000 rpm for 10 minutes. The pellets obtained were dissolved by adding 200 µL of DMSO and were made up to 2 mL. Absorbance was measured at 550 nm and the % viability was calculated from the mean absorbance of the test compound in respect to the mean absorbance of the control. The IC 50 values were reported as mean ± standard deviation of three independent experiments. One-way analysis of variance (ANOVA) and Student t-test were used to compare data using the Graph Pad Prism 5.0 software at a 95 % confidence limit. Table III . It is evident from the study that all the heterocyclic compounds synthesized in the present work had a cytotoxic effect on the tested cell lines. It is worth noting that compounds 9, 13, 15 and 21 exhibit IC 50 values comparable to the standard drug 5-flurouracil. From the results of the study, it is inferred that among the new heterocyclic compounds synthesized in the present research work, compounds with benzimidazole and benzoxazole moieties exhibit good cytotoxic activity. It is interesting to note that among the four benzimidazole compounds synthesized (4, 9, 15 and 21), three compounds, viz., From the data of cytotoxic activity, compounds 9, 15 and 21 were found to possess promising cytotoxic activity. This activity of the compounds may be due to the presence of dapsone, triazine and benzimidazole moieties. The remarkable antiproliferative activity of compound 13 may due to the presence of triazine and benzoxazole moieties.
RESULTS AND DISCUSSION

CONCLUSIONS
In the present study, syntheses of some new benzimidazoles, benzoxazoles, imidazoles and tetrazoles is described. All the compounds were evaluated for cytotoxic activity. Benzimidazoles 9, 13, 15 and 21 and benzoxazole 13 were found to be the most active compounds with a promising cytotoxic activity. It can be deduced from the results that benzimidazole and benzoxazole moiety can create potent cytotoxic compounds, whereas imidazole and tetrazole compounds show lower cytotoxic effects. Further studies and structural modifications are needed to increase the cytotoxic activity.
